InterMune plunges as US FDA calls for additional testing of IPF drug Esbriet ... The Pharma Letter InterMune saw a melt-down in its share price, after it revealed that the US Food and Drug Administration had issued a complete response letter for the New ... and more »

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment Vyvanse®

Aviva, Michael Page, Shire, WPP: UK, Irish Equity Preview Bloomberg ... Columbia has upheld the decision of the US Food and Drug Administration to grant five years of exclusivity to attention-deficit disorder drug Vyvanse. ... and more »

Hardy, Michael Page, Shire, WPP: UK, Irish Equity Preview Bloomberg ... Columbia has upheld the decision of the US Food and Drug Administration to grant five years of exclusivity to attention-deficit disorder drug Vyvanse. ... and more »

Market overview: Poor finish ShareCast Drug group Shire is still going well after the drug group announced the US Food and Drug Administration said that its hyperactivity treatment Vyvanse was ... Standard Chartered, Shire gain in London Middle East North Africa Financial Network London afternoon: Stocks get lift from Wall Street ShareCast all 8 news articles »